This site is intended for health professionals only

Thursday 22 August 2019
Share |

Latest News

Dupilumab reaches primary and secondary endpoints in paediatric trial

Thursday 8th August 2019
A pivotal Phase III trial evaluating Dupixent® (dupilumab) in severe atopic dermatitis in children has met its primary and secondary endpoints. 
The topline data show that for children with severe atopic dermatitis (covering nearly 60% of their skin surface on average), adding Dupixent to standard-of-care topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearing, itching and health-...
Thu, 23 May 2019
Inotersen is the world’s first and only subcutaneous RNA-targeting drug designed to reduce the production of human transthyretin protein
Thu, 23 May 2019
Inhaled combination for asthma treatment (indacaterol acetate, glycopyrronium bromide and mometasone furoate) was superior to the standard of care (long-acting beta-agonist/inhaled corticosteroid) in terms of lung function in a Phase II study
Wed, 22 May 2019
The worse outcome in women is largely attributable to the fact that women had about half the chance of having a shockable initial rhythm compared to men
Wed, 22 May 2019
Coronary angiography is an invasive procedure that provides an X-ray outline of the arteries supplying blood to the heart but there has been controversy over when to use it
Mon, 20 May 2019
Over 870,000 people have taken part in clinical trials in 2018/2019 and this number marks a significant step towards the NHS Long Term Plan’s goal of reaching one million participants by 2023/24
Fri, 17 May 2019
Experts would be able to see, for the first time, how a particular drug works within a patient at a cellular level or the molecular processes set in motion by a genetic mutation
Thu, 9 May 2019
The recommendation comes as a result of a significant volume of evidence that the use of PICO improves patient outcomes and provide additional benefits to the healthcare system at no extra cost versus standard care